Mercado Global de Saúde Materna – Tendências do Setor e Previsão para 2029

Análise e dimensão do mercado de saúde materna

A saúde da mulher é referida como saúde materna antes, durante e após o parto. Para garantir uma experiência feliz e gratificante na maioria dos casos e reduzir a morbilidade e morte materna nas restantes situações, incorpora as componentes de cuidados de saúde de planeamento familiar, cuidados pré-concepcionais, pré-natais e pós-natais. Em todo o mundo, especialmente nos países em desenvolvimento, a preocupação e o interesse pelo mercado da saúde materna crescem continuamente.

A Data Bridge Market Research analisa que o mercado de saúde materna, que foi de 14,05 mil milhões de dólares em 2021, dispararia para 28,00 mil milhões de dólares até 2029, e deverá passar por um CAGR de 9,00% durante o período de previsão de 2022 a 2029. Além dos insights de mercado, tais como o valor de mercado, a taxa de crescimento, os segmentos de mercado, a cobertura geográfica, os participantes do mercado e o cenário de mercado, o relatório de mercado com curadoria da equipa de estudos de mercado da O Data Bridge inclui também análise especializada aprofundada, epidemiologia do paciente, análise de pipeline, análise de preços e quadro regulamentar.

Âmbito e segmentação do mercado de saúde materna      

Market Definition

Women's health during pregnancy and childbirth is referred to as maternal health. It includes preconception, family planning, prenatal, and postnatal care to ensure, in most situations, a positive and fulfilling experience and, in some cases, to reduce maternal morbidity and transience.

Maternal Health Market Dynamics

Drivers

• Increased assistance to expectant mothers

The key elements accelerating the growth and demand of the maternal health market is the government's increased assistance to expectant mothers for the benefit of both mother and child. Additionally, throughout the projection period of 2022 to 2029, the robust R&D activity brought on by an increase in healthcare products will also help the market grow. Additionally, the market's expansion is being aided by the quick rise in emergency referral systems, maternal death audits, and improvements in government and administration of health services.

• Increasing investment for healthcare infrastructure

The significant factor influencing the growth rate of maternal health market is the rising healthcare expenditure, which helps improve its infrastructure. Also, various government organizations aim to improve the healthcare infrastructure by increasing funding, which will further influence the market dynamics.

• Growing concern about maternal health benefits

The market growth in the forecast period is also being supported by the rising number of pregnant women and the growing customer awareness of the benefits of maternal health. The maternal health market will continue to develop and present substantial growth prospects for the industry in the forecast period of 2022 to 2029 due to the rapid advancements in healthcare products, rising birth rates, and rising disposable income.

Opportunities

The market growth in the forecast period is also supported by the rising number of pregnant women and the growing customer awareness of maternal health benefits. The maternal health market will continue to develop and present substantial growth prospects for the industry in the forecast period of 2022 to 2029 due to the rapid advancements in healthcare products, rising birth rates, and rising disposable income.

Restraints/Challenges

The market for maternal health will be constrained in its growth by the restricted treatment options available, but it could face difficulties from the market's expansion due to the high initial expenditures.

This maternal health market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the maternal health market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Maternal Health Market Scope

The maternal health market is segmented on the basis of type, pregnancy, risk in pregnancy, complications, delivery type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

 Type

• Hormones
•  Nutritives
• Analgesics
• Anti-Infectives
• Others

 Pregnancy

• Intrauterine
• Ectopic
• Tubal
• Others

 Risk in Pregnancy

• High
• Molar

 Complications

• Miscarriage
• Premature Labor and Birth
• Others

 Delivery Type

• Vaginal Delivery
• Cesarian Section
• Others

Application

• Hospitals
• Clinics
• Household
• Others

Maternal Health Market Regional Analysis/Insights

The maternal health market is analysed and market size insights and trends are provided by country, type, pregnancy, risk in pregnancy, complications, delivery type and application as referenced above.

The countries covered in the maternal health market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the maternal health market owing to the rapid increase in the female population and significant rise in the number of pregnancies within the region. 

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and growing demand of advanced medical technology.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.

Análise do cenário competitivo e da participação no mercado da saúde materna

O panorama competitivo do mercado de saúde materna fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado da saúde materna.

Alguns dos principais players que operam no mercado da saúde materna são:

• Johnson & Johnson Private Limited (EUA)
• Jiovio Healthcare (Singapura)
• McKinsey & Company (EUA)
• MedTech Boston (Alemanha)
• Merck & Co., Inc.
• RAND Corporation (EUA)
• Desenvolvimento de produto SYNAPSE (EUA)
• Federação Internacional de Fabricantes e Associações Farmacêuticas (Suíça)
• Siemens (Alemanha)
• Terapêutica Ágil (EUA)
• Fuji Latex Co (Japão)
• Okamoto Industries Inc. (Japão)
• Reckitt Benckiser Group Plc (Reino Unido)
• Sanofi (Índia)

SKU-58832